department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

the cabinet

Drugs

8,127 products tracked · 368 matching

★ save view ↓export CSV

phase

all Marketed Phase 3 Phase 2 Phase 1 Preclinical

sort

catalysts recent name

therapeutic area

all Oncology1831 Infectious Disease718 Cardiology425 Pulmonology396 Immunology371 Ophthalmology368 Dermatology300 Women's Health131

Marketed
(brimonidine tartrate + timolol maleate)
Brimonidine Tartrate + Timolol Maleate ((brimonidine tartrate + timolol maleate))
Glaucoma Sentiss Pharmaceuticals LLC
Marketed
(cyclopentolate hydrochloride + phenylephrine hydrochloride)
Cyclomydril ((cyclopentolate hydrochloride + phenylephrine hydrochloride))
Mydriasis$ALC ALCON INC
Marketed
(dexamethasone + tobramycin)
Tobradex ST ((dexamethasone + tobramycin))
Ocular Inflammation$HROW HARROW, INC.

page 3 of 13

Marketed

(dextromethorphan + promethazine)

Promethazine DM ((dextromethorphan [INN] + promethazine [INN]))

Nasopharyngitis (Common Cold) PAI Holding Co LLC

Phase 2

(difluprednate + povidone iodine)

(difluprednate + povidone iodine [USP])

Viral Conjunctivitis iView Therapeutics Inc

Marketed

(gramicidin + neomycin sulfate + polymyxin B)

Neomycin + Polymyxin B Sulfates + Gramicidin ((gramicidin [INN] + neomycin sulfate + polymyxin B [INN]))

Bacterial Conjunctivitis Sciegen Pharmaceuticals Inc

Marketed

(hydrocortisone + neomycin sulfate + polymyxin B)

Casporyn HC ((hydrocortisone [INN] + neomycin sulfate + polymyxin B [INN]))

Otitis Externa Casper Pharma LLC

Marketed

(ketorolac tromethamine + phenylephrine hydrochloride)

Ketorolac Tromethamine + Phenylephrine Hydrochloride ((ketorolac tromethamine + phenylephrine hydrochloride))

Ocular Pain (Eye Pain) Lupin Ltd

Marketed

(latanoprost + netarsudil mesylate)

Rocklatan ((latanoprost + netarsudil mesylate))

Ocular Hypertension$ALC ALCON INC

Marketed

(naphazoline + pheniramine maleate)

Naphazoline Hydrochloride + Pheniramine Maleate ((naphazoline [INN] + pheniramine maleate))

Allergic Conjunctivitis Altaire Pharmaceuticals Inc

Phase 3

(neltependocel + Y-27632)

Vyznova (neltependocel [INN])

Corneal Edema Aurion Biotech Inc

Marketed

(polymyxin B + trimethoprim sulfate)

Polymyxin B + Trimethoprim Sulfate Pacific ((polymyxin B [INN] + trimethoprim sulfate))

Bacterial Conjunctivitis Pacific Pharmaceuticals USA

Marketed

(prednisolone sodium phosphate + sulfacetamide sodium)

Sulfacetamide Sodium + Prednisolone Sodium Phosphate ((prednisolone sodium phosphate + sulfacetamide sodium))

Anterior Uveitis Bausch Health US LLC

Phase 3

(riboflavin + sodium iodide)

(riboflavin [INN] + sodium iodide [USP])

Keratoconus Epion Therapeutics Inc

Preclinical

(rifampin + polymyxin B + trimethoprim)

(rifampin + polymyxin B [INN] + trimethoprim)

Bacterial Keratitis University of Rochester

Phase 3

Wet (Neovascular / Exudative) Macular Degeneration$FDMT 4D Molecular Therapeutics, Inc.

Preclinical

Macular Degeneration 6S Pharma LLC

Phase 2

Keratoconjunctivitis Sicca (Dry Eye) Aramis Biosciences Inc

Preclinical

no indication$MGTX MeiraGTx Holdings plc

Phase 2

Juvenile Macular Degeneration (Stargardt Disease) AAVantgarde Bio Srl

Phase 2

Polypoidal Choroidal Vasculopathy Avirmax Inc

Preclinical

Retinal Degeneration$ABEO ABEONA THERAPEUTICS INC.

Preclinical

Juvenile Macular Degeneration (Stargardt Disease)$ABEO ABEONA THERAPEUTICS INC.

Preclinical

Optic Neuropathy$ABEO ABEONA THERAPEUTICS INC.

Phase 2

Juvenile Macular Degeneration (Stargardt Disease) Ascidian Therapeutics Inc

Preclinical

AChE Inhibitors

Acne Vulgaris Attillaps Holdings Inc

Preclinical

Retinal Vein Occlusion Allgenesis Biotherapeutics Inc

Preclinical

Retinitis Pigmentosa (Retinitis) Agnos Therapeutics Inc

Preclinical

Diabetic Macular Edema$AMPH Amphastar Pharmaceuticals, Inc.

Phase 2

Retinal Vein Occlusion Annexin Pharmaceuticals AB